{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:51Z","timestamp":1791919071156,"version":"4.3.4"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K16709"],"award-info":[{"award-number":["21K16709"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03202"],"award-info":[{"award-number":["22H03202"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Alveolar soft part sarcoma is a rare neoplasm of uncertain histogenesis that belongs to a newly defined category of ultra-rare sarcomas. The neoplasm is characterized by a specific chromosomal translocation, der (17) t(X; 17)(p11.2;q25), that results in ASPSCR1\u2013TFE3 gene fusion. The natural history of alveolar soft part sarcoma describes indolent behaviour with slow progression in deep soft tissues of the extremities, trunk and head\/neck in adolescents and young adults. A high rate of detection of distant metastasis at presentation has been reported, and the most common metastatic sites in decreasing order of frequency are the lung, bone and brain. Complete surgical resection remains the standard treatment strategy, whereas radiotherapy is indicated for patients with inadequate surgical margins or unresectable tumours. Although alveolar soft part sarcoma is refractory to conventional doxorubicin-based chemotherapy, monotherapy or combination therapy using tyrosine kinase inhibitors and immune checkpoint inhibitors have provided antitumor activity and emerged as new treatment strategies. This article provides an overview of the current understanding of this ultra-rare sarcoma and recent advancements in treatments according to the clinical stage of alveolar soft part sarcoma.<\/jats:p>","DOI":"10.1093\/jjco\/hyad102","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T03:56:20Z","timestamp":1693022180000},"page":"1009-1018","source":"Crossref","is-referenced-by-count":33,"title":["Advances in treatment of alveolar soft part sarcoma: an updated review"],"prefix":"10.1093","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4257-9180","authenticated-orcid":false,"given":"Tomohiro","family":"Fujiwara","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences , Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-850X","authenticated-orcid":false,"given":"Toshiyuki","family":"Kunisada","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences , Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-4142","authenticated-orcid":false,"given":"Eiji","family":"Nakata","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences , Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Hospital , Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yanai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Hospital , Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1099-7436","authenticated-orcid":false,"given":"Tomoki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Mie University , Tsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5138-8952","authenticated-orcid":false,"given":"Kazuhiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical Sciences, Oita University , Yufu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences , Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"2023110906355667600_ref1","doi-asserted-by":"crossref","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"2023110906355667600_ref2","volume-title":"WHO Classification of Tumours of Soft Tissue and Bone","author":"WHO_Classification_of_Tumours_Editorial_Board","year":"2020","edition":"5th"},{"key":"2023110906355667600_ref3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/CCO.0000000000000652","article-title":"Novel therapeutic options for alveolar soft part sarcoma: antiangiogenic therapy, immunotherapy and beyond","volume":"32","author":"Brahmi","year":"2020","journal-title":"Curr Opin Oncol"},{"key":"2023110906355667600_ref4","doi-asserted-by":"crossref","first-page":"100775","DOI":"10.1016\/j.currproblcancer.2021.100775","article-title":"Advances in the management of alveolar soft part sarcoma","volume":"45","author":"O'Sullivan Coyne","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"2023110906355667600_ref5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.currproblcancer.2019.05.006","article-title":"Diagnostic classification of soft tissue malignancies: a review and update from a surgical pathology perspective","volume":"43","author":"Cloutier","year":"2019","journal-title":"Curr Probl Cancer"},{"key":"2023110906355667600_ref6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.onc.1204074","article-title":"The der (17) t (X; 17)(p11; q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25","volume":"20","author":"Ladanyi","year":"2001","journal-title":"Oncogene"},{"key":"2023110906355667600_ref7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1470-2045(19)30286-4","article-title":"Personalised management of alveolar soft part sarcoma: a promising phase 2 study","volume":"20","author":"Penel","year":"2019","journal-title":"Lancet Oncol"},{"key":"2023110906355667600_ref8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pbc.23252","article-title":"Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database","volume":"57","author":"Ferrari","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"2023110906355667600_ref9","volume-title":"Bone and Soft Tissue Tumor Registry in Japan","author":"The Japanese Orthopaedic Association Musculoskeletal Tumour Committee","year":"2018"},{"key":"2023110906355667600_ref10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jso.24183","article-title":"Prognostic factors in alveolar soft part sarcoma: a SEER analysis","volume":"113","author":"Wang","year":"2016","journal-title":"J Surg Oncol"},{"key":"2023110906355667600_ref11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4055\/cios.2014.6.1.80","article-title":"Alveolar soft part sarcoma: clinical presentation, treatment and outcome in a series of 19 patients","volume":"6","author":"Cho","year":"2014","journal-title":"Clin Orthop Surg"},{"key":"2023110906355667600_ref12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1365-2559.1999.035005411.x","article-title":"Primary alveolar soft part sarcoma of bone","volume":"35","author":"Fletcher","year":"1999","journal-title":"Histopathology"},{"key":"2023110906355667600_ref13","doi-asserted-by":"crossref","first-page":"152078","DOI":"10.1016\/j.anndiagpath.2022.152078","article-title":"Primary intraosseous alveolar soft part sarcoma: report of two cases with radiologic-pathologic correlation","volume":"62","author":"Pena-Burgos","year":"2023","journal-title":"Ann Diagn Pathol"},{"key":"2023110906355667600_ref14","doi-asserted-by":"crossref","first-page":"699.e1","DOI":"10.1016\/j.wneu.2016.02.005","article-title":"Primary intracranial alveolar soft-part sarcoma: report of two cases and a review of the literature","volume":"90","author":"Tao","year":"2016","journal-title":"World Neurosurg"},{"key":"2023110906355667600_ref15","first-page":"106689692311525","article-title":"Primary intracranial alveolar soft part sarcoma: a report of 3 cases","volume":"10668969231152573","author":"Rao","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"2023110906355667600_ref16","first-page":"304","article-title":"Orbital alveolar soft part sarcoma: a report of 8 cases and review of the literature","volume":"15","author":"Hei","year":"2018","journal-title":"Oncol Lett"},{"key":"2023110906355667600_ref17","first-page":"1156","article-title":"Alveolar soft-part sarcoma of the tongue","volume":"24","author":"Aiken","year":"2003","journal-title":"Am J Neuroradiol"},{"key":"2023110906355667600_ref18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3346\/jkms.2007.22.2.369","article-title":"Primary alveolar soft part sarcoma of the lung","volume":"22","author":"Kim","year":"2007","journal-title":"J Korean Med Sci"},{"key":"2023110906355667600_ref19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2559.1997.2690871.x","article-title":"Primary alveolar soft-part sarcoma of the mediastinum: a clinicopathological and immunohistochemical study of two cases","volume":"31","author":"Flieder","year":"1997","journal-title":"Histopathology"},{"key":"2023110906355667600_ref20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4081\/cp.2013.e26","article-title":"Alveolar soft part sarcoma: unusual etiology of mediastinal mass in an adolescent","volume":"3","author":"Schenning","year":"2013","journal-title":"Clinics and Practice"},{"key":"2023110906355667600_ref21","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/01.pas.0000213298.34520.2b","article-title":"Alveolar soft-part sarcoma of the urinary bladder with urethral recurrence: a unique case with emphasis on differential diagnoses and diagnostic utility of an immunohistochemical panel including TFE3","volume":"30","author":"Amin","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2023110906355667600_ref22","first-page":"106689692211491","article-title":"Primary alveolar soft-part sarcoma (ASPS) of the prostate: report of a deceptive case","author":"Daneshpajouhnejad","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"2023110906355667600_ref23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/PGP.0000000000000700","article-title":"Alveolar soft part sarcoma of uterine corpus in a young female: a case report with review of literature","volume":"40","author":"Vishwajeet","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"2023110906355667600_ref24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/030089169007600121","article-title":"Alveolar soft part sarcoma of the vagina","volume":"76","author":"Cannelli","year":"1990","journal-title":"Tumori"},{"key":"2023110906355667600_ref25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1186\/s12885-022-09968-5","article-title":"Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study","volume":"22","author":"Fujiwara","year":"2022","journal-title":"BMC Cancer"},{"key":"2023110906355667600_ref26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.surg.2020.06.007","article-title":"Characterization of alveolar soft part sarcoma using a large national database","volume":"168","author":"Hagerty","year":"2020","journal-title":"Surgery"},{"key":"2023110906355667600_ref27","doi-asserted-by":"crossref","first-page":"e26805","DOI":"10.1097\/MD.0000000000026805","article-title":"The current management of alveolar soft part sarcomas","volume":"100","author":"Chang","year":"2021","journal-title":"Medicine"},{"key":"2023110906355667600_ref28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2214\/AJR.14.12462","article-title":"Imaging features of alveolar soft part sarcoma: a report from Children\u2019s Oncology Group Study ARST0332","volume":"203","author":"McCarville","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"2023110906355667600_ref29","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1007\/s00330-018-5903-3","article-title":"Alveolar soft-part sarcoma: can MRI help discriminating from other soft-tissue tumors? A study of the French sarcoma group","volume":"29","author":"Crombe","year":"2019","journal-title":"Eur Radiol"},{"key":"2023110906355667600_ref30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jjco\/hys060","article-title":"A case of an alveolar soft part sarcoma with secondary scapular involvement","volume":"42","author":"Ohshika","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"2023110906355667600_ref31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5858\/2007-131-488-ASPS","article-title":"Alveolar soft part sarcoma","volume":"131","author":"Zarrin-Khameh","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"2023110906355667600_ref32","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/jcp.2005.031120","article-title":"Alveolar soft-part sarcoma: a review and update","volume":"59","author":"Folpe","year":"2006","journal-title":"J Clin Pathol"},{"key":"2023110906355667600_ref33","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.5858\/arpa.2014-0385-RS","article-title":"Alveolar soft part sarcoma","volume":"139","author":"Jaber","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"2023110906355667600_ref34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00125480-199905000-00001","article-title":"Alveolar soft part sarcoma: a review and update","volume":"6","author":"Ord\u00f3\u00f1ez","year":"1999","journal-title":"Adv Anat Pathol"},{"key":"2023110906355667600_ref35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/PDM.0b013e31815d68d7","article-title":"Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues","volume":"17","author":"Pang","year":"2008","journal-title":"Diagn Mol Pathol"},{"key":"2023110906355667600_ref36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.humpath.2011.05.004","article-title":"Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript","volume":"43","author":"Tsuji","year":"2012","journal-title":"Hum Pathol"},{"key":"2023110906355667600_ref37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jamaoncol.2018.4490","article-title":"Diagnosis, prognosis, and treatment of alveolar soft-part sarcoma: a review","volume":"5","author":"Paoluzzi","year":"2019","journal-title":"JAMA Oncol"},{"key":"2023110906355667600_ref38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/gcc.22803","article-title":"Genetic diversity in alveolar soft part sarcoma: a subset contain variant fusion genes, highlighting broader molecular kinship with other MiT family tumors","volume":"59","author":"Dickson","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"2023110906355667600_ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-022-02119-7","article-title":"Soft-tissue sarcoma in adolescents and young adults","volume":"28","author":"Kunisada","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"2023110906355667600_ref40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13569-016-0060-4","article-title":"UK guidelines for the management of soft tissue sarcomas","volume":"6","author":"Dangoor","year":"2016","journal-title":"Clinical sarcoma research"},{"key":"2023110906355667600_ref41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.6004\/jnccn.2018.0025","article-title":"Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Mehren","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"2023110906355667600_ref42","doi-asserted-by":"crossref","first-page":"e26953","DOI":"10.1002\/pbc.26953","article-title":"Alveolar soft part sarcoma in children and young adults: a report of 69 cases","volume":"65","author":"Flores","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2023110906355667600_ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19890101)63:1<1::AID-CNCR2820630102>3.0.CO;2-E","article-title":"Alveolar soft-part sarcoma. A clinico-pathologic study of half a century","volume":"63","author":"Lieberman","year":"1989","journal-title":"Cancer"},{"key":"2023110906355667600_ref44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000071199","article-title":"Alveolar soft part sarcoma in Japan: multi-institutional study of 57 patients from the Japanese musculoskeletal oncology group","volume":"65","author":"Ogose","year":"2003","journal-title":"Oncology"},{"key":"2023110906355667600_ref45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(20010201)91:3<585::AID-CNCR1038>3.0.CO;2-0","article-title":"Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution","volume":"91","author":"Portera","year":"2001","journal-title":"Cancer"},{"key":"2023110906355667600_ref46","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1023\/A:1026579623136","article-title":"Alveolar soft part sarcoma in children and adolescents: a report from the Soft-Tissue Sarcoma Italian Cooperative Group","volume":"11","author":"Casanova","year":"2000","journal-title":"Ann Oncol"},{"key":"2023110906355667600_ref47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijgo.2013.04.025","article-title":"Ovarian function preserved by carbon-ion radiotherapy for alveolar soft-part sarcoma","volume":"123","author":"Nakao","year":"2013","journal-title":"Int J Gynecol Obstet"},{"key":"2023110906355667600_ref48","doi-asserted-by":"crossref","first-page":"100893","DOI":"10.1016\/j.adro.2021.100893","article-title":"Pembrolizumab after carbon ion radiation therapy for alveolar soft part sarcoma shows a remarkable abscopal effect: a case report","volume":"7","author":"Okamoto","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"2023110906355667600_ref49","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26942","article-title":"Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005)","volume":"65","author":"Brennan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2023110906355667600_ref50","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0959-8049(03)00264-8","article-title":"Chemotherapy in alveolar soft part sarcomas: what do we know?","volume":"39","author":"Reichardt","year":"2003","journal-title":"Eur J Cancer"},{"key":"2023110906355667600_ref51","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.athoracsur.2009.04.144","article-title":"Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival","volume":"88","author":"Blackmon","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2023110906355667600_ref52","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jjco\/hyab033","article-title":"Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: a population-based cohort study","volume":"51","author":"Zhang","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"2023110906355667600_ref53","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/BF02385270","article-title":"Surgery for multiple lung metastases from alveolar soft-part sarcoma","volume":"27","author":"Kodama","year":"1997","journal-title":"Surg Today"},{"key":"2023110906355667600_ref54","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/annonc\/mdq644","article-title":"Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect","volume":"22","author":"Stacchiotti","year":"2011","journal-title":"Ann Oncol"},{"key":"2023110906355667600_ref55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijrobp.2009.02.007","article-title":"Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases","volume":"76","author":"Flannery","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023110906355667600_ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/907179","article-title":"Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literature","volume":"2012","author":"Ogura","year":"2012","journal-title":"Sarcoma"},{"key":"2023110906355667600_ref57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jocn.2021.09.002","article-title":"Stereotactic radiosurgery in alveolar soft part sarcoma brain metastases: case series and literature review","volume":"93","author":"Lim","year":"2021","journal-title":"J Clin Neurosci"},{"key":"2023110906355667600_ref58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3892\/ol.2015.3889","article-title":"Alveolar soft-part sarcoma in the left forearm with cardiac metastasis: a case report and literature review","volume":"11","author":"Chen","year":"2016","journal-title":"Oncol Lett"},{"key":"2023110906355667600_ref59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0030-1249093","article-title":"Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh","volume":"222","author":"Hanzer","year":"2010","journal-title":"Klin Padiatr"},{"key":"2023110906355667600_ref60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd3073","article-title":"Pazopanib","volume":"9","author":"Bukowski","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"2023110906355667600_ref61","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"Van Der Graaf","year":"2012","journal-title":"The Lancet"},{"key":"2023110906355667600_ref62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.2018-0464","article-title":"A phase II trial of pazopanib in patients with metastatic alveolar soft part sarcoma","volume":"24","author":"Kim","year":"2019","journal-title":"Oncologist"},{"key":"2023110906355667600_ref63","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ccell.2014.10.003","article-title":"Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment","volume":"26","author":"Goodwin","year":"2014","journal-title":"Cancer Cell"},{"key":"2023110906355667600_ref64","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1634\/theoncologist.2017-0161","article-title":"Activity of pazopanib and trabectedin in advanced alveolar soft part sarcoma","volume":"23","author":"Stacchiotti","year":"2018","journal-title":"Oncologist"},{"key":"2023110906355667600_ref65","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00000658-199905000-00002","article-title":"Pulmonary metastases from soft tissue sarcoma: analysis of patterns of disease and postmetastasis survival","volume":"229","author":"Billingsley","year":"1999","journal-title":"Ann Surg"},{"key":"2023110906355667600_ref66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5301\/tj.5000617","article-title":"Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma","volume":"103","author":"Jagodzinska-Mucha","year":"2017","journal-title":"Tumori"},{"key":"2023110906355667600_ref67","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10637-016-0390-3","article-title":"A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib","volume":"34","author":"Li","year":"2016","journal-title":"Invest New Drugs"},{"key":"2023110906355667600_ref68","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/pbc.24683","article-title":"Paediatric and adolescent alveolar soft part sarcoma: a joint series from European cooperative groups","volume":"60","author":"Orbach","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"2023110906355667600_ref69","doi-asserted-by":"crossref","first-page":"10523","DOI":"10.1200\/jco.2009.27.15_suppl.10523","article-title":"Activity of cediranib, a highly potent and selective VEGF signaling inhibitor, in alveolar soft part sarcoma","volume":"27","author":"Gardner","year":"2009","journal-title":"J Clin Oncol"},{"key":"2023110906355667600_ref70","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(19)30215-3","article-title":"Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial","volume":"20","author":"Judson","year":"2019","journal-title":"Lancet Oncol"},{"key":"2023110906355667600_ref71","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.2012.47.4288","article-title":"Cediranib for metastatic alveolar soft part sarcoma","volume":"31","author":"Kummar","year":"2013","journal-title":"J Clin Oncol"},{"key":"2023110906355667600_ref72","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1158\/1078-0432.CCR-22-2145","article-title":"Randomized phase II trial of sunitinib or cediranib in alveolar soft part sarcoma","volume":"29","author":"Nguyen","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2023110906355667600_ref73","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.3390\/ijms23105689","article-title":"Correlation of immunological and molecular profiles with response to crizotinib in alveolar soft part sarcoma: an exploratory study related to the EORTC 90101 \u201cCREATE\u201d trial","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2023110906355667600_ref74","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/annonc\/mdx774","article-title":"Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of cancer (EORTC) phase II trial 90101 \u2018CREATE\u2019","volume":"29","author":"Sch\u00f6ffski","year":"2018","journal-title":"Ann Oncol"},{"key":"2023110906355667600_ref75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1078-0432.CCR-21-2480","article-title":"Clinical activity of single-agent cabozantinib (XL184), a multi-receptor tyrosine kinase inhibitor, in patients with refractory soft-tissue sarcomas","volume":"28","author":"O'Sullivan Coyne","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2023110906355667600_ref76","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1470-2045(19)30153-6","article-title":"Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial","volume":"20","author":"Wilky","year":"2019","journal-title":"Lancet Oncol"},{"key":"2023110906355667600_ref77","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(06)70729-X","article-title":"Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma","volume":"7","author":"Azizi","year":"2006","journal-title":"Lancet Oncol"},{"key":"2023110906355667600_ref78","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/CAD.0b013e3283514b8c","article-title":"Durable clinical activity of single-agent bevacizumab in a nonagenarian patient with metastatic alveolar soft part sarcoma","volume":"23","author":"Mir","year":"2012","journal-title":"Anticancer Drugs"},{"key":"2023110906355667600_ref79","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1200\/JCO.2008.20.9890","article-title":"Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas","volume":"27","author":"George","year":"2009","journal-title":"J Clin Oncol"},{"key":"2023110906355667600_ref80","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cncr.30379","article-title":"Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor","volume":"123","author":"Schuetze","year":"2017","journal-title":"Cancer"},{"key":"2023110906355667600_ref81","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1002\/cncr.27582","article-title":"Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor\u2013associated tumors: results of a multicenter phase 2 trial","volume":"118","author":"Wagner","year":"2012","journal-title":"Cancer"},{"key":"2023110906355667600_ref82","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1634\/theoncologist.2016-0064","article-title":"Efficacy of trabectedin in patients with advanced translocation-related sarcomas: pooled analysis of two phase II studies","volume":"22","author":"Takahashi","year":"2017","journal-title":"Oncologist"},{"key":"2023110906355667600_ref83","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40425-017-0301-y","article-title":"Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials","volume":"5","author":"Groisberg","year":"2017","journal-title":"J Immunother Cancer"},{"key":"2023110906355667600_ref84","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/MPH.0000000000000571","article-title":"Treatment of metastatic, refractory alveolar soft part sarcoma: case reports and literature review of treatment options in the era of targeted therapy","volume":"38","author":"Kuo","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"2023110906355667600_ref85","first-page":"1","article-title":"Positive tumor response to combined checkpoint inhibitors in a patient with refractory alveolar soft part sarcoma: a case report","author":"Conley","year":"2018","journal-title":"J Glob Oncol"},{"key":"2023110906355667600_ref86","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.radcr.2018.05.013","article-title":"Pseudoprogression of CNS metastatic disease of alveolar soft part sarcoma during anti-PDL1 treatment","volume":"13","author":"Vander Jagt","year":"2018","journal-title":"Radiol Case Rep"},{"key":"2023110906355667600_ref87","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1470-2045(22)00392-8","article-title":"Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial","volume":"23","author":"Somaiah","year":"2022","journal-title":"Lancet Oncol"},{"key":"2023110906355667600_ref88","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1158\/1078-0432.CCR-19-3335","article-title":"Facts and hopes in immunotherapy of soft-tissue sarcomas","volume":"26","author":"Mart\u00edn-Broto","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2023110906355667600_ref89","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27987","article-title":"Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS)","volume":"66","author":"Cohen","year":"2019","journal-title":"Pediatric blood & cancer"},{"key":"2023110906355667600_ref90","article-title":"Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma","volume":"9","author":"Liu","year":"2021","journal-title":"Ann Transl Med"},{"key":"2023110906355667600_ref91","doi-asserted-by":"crossref","DOI":"10.1186\/s13569-016-0064-0","article-title":"Response to anti-PD1 therapy with nivolumab in metastatic sarcomas","volume":"6","author":"Paoluzzi","year":"2016","journal-title":"Clinical sarcoma research"},{"key":"2023110906355667600_ref92","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-20-2819","article-title":"Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study","volume":"26","author":"Shi","year":"2020","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"2023110906355667600_ref93","author":"U.S. National Library of Medicine"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/53\/11\/1009\/52871438\/hyad102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/53\/11\/1009\/52871438\/hyad102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T11:39:44Z","timestamp":1699529984000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/53\/11\/1009\/7251339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":93,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,8,25]]},"published-print":{"date-parts":[[2023,11,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyad102","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,8,25]]}}}